Myron Holubiak
2020
In 2020, Myron Holubiak earned a total compensation of $875K as Chief Executive Officer at Citius Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $285,000 |
---|---|
Option Awards | $140,035 |
Salary | $450,000 |
Total | $875,035 |
Holubiak received $450K in salary, accounting for 51% of the total pay in 2020.
Holubiak also received $285K in non-equity incentive plan and $140K in option awards.
Rankings
In 2020, Myron Holubiak's compensation ranked 9,152nd out of 13,090 executives tracked by ExecPay. In other words, Holubiak earned more than 30.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,152 | 30th |
Manufacturing | 3,913 | 30th |
Chemicals And Allied Products | 1,587 | 30th |
Drugs | 1,387 | 29th |
Pharmaceutical Preparations | 1,022 | 30th |
Holubiak's colleagues
We found three more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2020.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018